Skip to main content

Closed

LSTA: Lisata Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-83.0% / yr

Operating margin-10178.2%

ROIC-157.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio4.23×

Lisata Therapeutics, Inc.

LSTANASDAQ Capital Market·USD·Closed

Lisata Therapeutics, Inc.

LSTANASDAQ·USD·Closed

$0.99

−3.88%

$0.99

−$0.04 (3.88%)

52W Range

0thpctl

Volume

0.55×avg

Mkt Cap

9.02MUSD

P/E

-0.5TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.55×avg

Market Cap

9.02MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings